Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Networks in Cancer

被引：6

作者：

Baldini, Nicola ^{[1
,2
]}

De Milito, Angelo ^{[3
]}

Feron, Olivier ^{[4
]}

Gillies, Robert J. ^{[5
]}

Michiels, Carine ^{[6
]}

Otto, Angela M. ^{[7
]}

Pastorekova, Silvia ^{[8
]}

Pedersen, Stine F. ^{[9
]}

Porporato, Paolo E. ^{[4
,10
]}

Sonveaux, Pierre ^{[4
]}

Supuran, Claudiu T. ^{[11
]}

Avnet, Sofia ^{[1
]}

机构：

[1] Rizzoli Orthopaed Inst, Bologna, Italy

[2] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy

[3] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[4] Catholic Univ Louvain, IREC, Pole Pharmacol, Brussels, Belgium

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] Univ Namur, Namur Res Inst Life Sci NARILIS, Namur, Belgium

[7] Tech Univ Munich, Munich Sch Bioengn, Munich, Germany

[8] Slovak Acad Sci, Biomed Res Ctr, Bratislava, Slovakia

[9] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark

[10] Univ Torino, Mol Biotechnol Ctr, Dept Mol Biotechnol, Turin, Italy

[11] Univ Florence, Neurofarba Dept, Florence, Italy

来源：

FRONTIERS IN PHARMACOLOGY | 2017年 / 8卷

关键词：

tumor metabolism; proton dynamics; tumor microenvironment; cancer imaging; cancer therapy;

D O I：

10.3389/fphar.2017.00411

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cancers are metabolic entities wherein cancer cells adapt their metabolism to their oncogenic agenda and microenvironmental influences. Metabolically different cancer cell subpopulations collaborate to optimize nutrient delivery with respect to immediate bioenergetic and biosynthetic needs. They can also metabolically exploit host cells. These metabolic networks are directly linked with cancer progression, treatment resistance and relapse. Conversely, metabolic alterations in cancer are exploited for anticancer therapy, imaging and personalized medicine. These topics were addressed at the 3rd annual meeting of the International Society of Cancer Metabolism (ISCaM) in Brussels, Belgium, on 26-29 October 2016.

引用

页数：5

共 34 条

[21] Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
Chaube, Balkrishna
Malvi, Parmanand
FRONTIERS IN ONCOLOGY, 2023, 13
[22] CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy
Kranz, Lena M.
Beck, Jan D.
Grunwitz, Christian
Hotz, Christian
Vormehr, Mathias
Diken, Mustafa
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (10) : 2272 - 2279
[23] CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy
Kranz, Lena M.
Birtel, Matthias
Krienke, Christina
Grunwitz, Christian
Petschenka, Jutta
Reuter, Kerstin C.
van de Roemer, Niels
Vascotto, Fulvia
Vormehr, Mathias
Kreiter, Sebastian
Diken, Mustafa
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (01) : 213 - 221
[24] CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany
Kranz, Lena M.
Birtel, Matthias
Hilscher, Lina
Grunwitz, Christian
Petschenka, Jutta
Vascotto, Fulvia
Vormehr, Mathias
Voss, Ralf-Holger
Kreiter, Sebastian
Diken, Mustafa
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (11) : 2805 - 2812
[25] CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy May 6-8 2014, Mainz, Germany
Diken, Mustafa
Boegel, Sebastian
Grunwitz, Christian
Kranz, Lena M.
Reuter, Kerstin
van de Roemer, Niels
Vascotto, Fulvia
Vormehr, Mathias
Kreiter, Sebastian
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (10) : 3090 - 3100
[26] Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming
Liu, Pengcheng
Huang, Fuxin
Lin, Peixu
Liu, Jiayao
Zhou, Pincheng
Wang, Jie
Sun, Huanhuan
Xing, Fan
Ma, Haiqing
JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
[27] Zinc-Carnosine Metallodrug Network as Dual Metabolism Inhibitor Overcoming Metabolic Reprogramming for Efficient Cancer Therapy
Lei, Lingling
Nan, Bin
Yang, Fengrui
Guan, Guoqiang
Xu, Juntao
Xu, Li
Yue, Renye
Wang, Youjuan
Huan, Shuangyan
Yin, Xia
Zhang, Xiao-Bing
Song, Guosheng
NANO LETTERS, 2023, 23 (07) : 2659 - 2668
[28] Polyamines - A New Metabolic Switch: Crosstalk With Networks Involving Senescence, Crop Improvement, and Mammalian Cancer Therapy
Sobieszczuk-Nowicka, Ewa
Paluch-Lubawa, Ewelina
Mattoo, Autar K.
Arasimowicz-Jelonek, Magdalena
Gregersen, Per L.
Pacak, Andrzej
FRONTIERS IN PLANT SCIENCE, 2019, 10
[29] Association of cancer metabolism-related proteins with oral carcinogenesis – indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
Martin Grimm
Marcel Cetindis
Max Lehmann
Thorsten Biegner
Adelheid Munz
Peter Teriete
Wiebke Kraut
Siegmar Reinert
Journal of Translational Medicine, 12
[30] A second Warburg-like effect in cancer metabolism: The metabolic shift of glutamine-derived nitrogen A shift in glutamine-derived nitrogen metabolism from glutaminolysis to de novo nucleotide biosynthesis contributes to malignant evolution of cancer
Kodama, Manabu
Nakayama, Keiichi I.
BIOESSAYS, 2020, 42 (12)

← 1 2 3 4 →